Skip to content

The effect of quinine on food intake: oral sham feeding versus intragastric delivery

The effect of quinine on food intake: oral sham feeding versus intragastric delivery - Quinine and food intake

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON48861
Enrollment
45
Registered
2018-06-27
Start date
2018-08-17
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity overweight

Interventions

Oral sham feeding of and intragastric delivery of quinine (a bitter agent) versus placebo.

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Based on medical history and previous examination, no gastrointestinal complaints can be defined. - Age from 18 until 65 years. This study will include healthy adult subjects (male and female). - BMI from 18 until 25 kg/m2 - Bodyweight stable over at least the last 6 months (up until 5% weight change allowed)

Exclusion criteria

Exclusion criteria: - History of severe cardiovascular, respiratory, urogenital, gastrointestinal/ hepatic, hematological/immunologic, HEENT (head, ears, eyes, nose, throat), dermatological/connective tissue, musculoskeletal, metabolic/nutritional, endocrine, neurological/psychiatric diseases, allergy, major surgery and/or laboratory assessments which might limit participation in or completion of the study protocol. The severity of the disease (major interference with the execution of the experiment or potential influence on the study outcomes) will be decided by the principal investigator. - Use of medication that can influence study end-points (to be discussed by medical doctor and principal investigator), including vitamin supplementation, within 14 days prior to testing - Administration of investigational drugs or participation in any scientific intervention study which may interfere with this study (to be decided by the principle investigator), in the 180 days prior to the study - Major abdominal surgery interfering with gastrointestinal function (uncomplicated appendectomy and hysterectomy allowed, and other surgery upon judgement of medical doctor and principle investigator) - Dieting (medically prescribed, vegetarian, diabetic, macrobiological, biological dynamic) - Unwillingness to eat lasagna bolognese meal - Pregnancy, lactation - Excessive alcohol consumption (>20 alcoholic consumptions per week) - Smoking - Non-tasters of bitter

Design outcomes

Primary

MeasureTime frame
Food intake during an ad libitum pasta meal in the form of a pre made lasagna.

Secondary

MeasureTime frame
VAS scores for satiety and GI symptoms. Heart rate variability (HRV)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)